Intellia Therapeutics
NTLA
#5862
Rank
โ‚น96.34 B
Marketcap
โ‚น831.74
Share price
1.33%
Change (1 day)
-26.70%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2025 (TTM): -โ‚น368.70

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น388.57. In 2024 the company made an earnings per share (EPS) of -โ‚น477.75 an increase over its 2023 EPS that were of -โ‚น492.31.

EPS history for Intellia Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น368.70-22.83%
2024-โ‚น477.75-2.96%
2023-โ‚น492.31-12.46%
2022-โ‚น562.3864.36%
2021-โ‚น342.1656.67%
2020-โ‚น218.40
2018-โ‚น181.096.99%
2017-โ‚น169.2671.4%
2016-โ‚น98.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น157.43-59.48%๐Ÿ‡บ๐Ÿ‡ธ USA